Venture Capital · Or Yehuda (Israel), Menlo Park (United States) · Founded 2001
Peregrine Ventures is a leading global life science venture capital fund that invests in and supports life-changing healthcare opportunities. They leverage decades of entrepreneurial experience to build successful companies and provide strategic guidance throughout a company's lifecycle. Peregrine focuses on improving patients' quality of life through innovative medical technologies.
Seed, Series A, Series B, Series C
Digital Health, MedTech, Pharma
Aleph Farms, Althea Medical, ArTack Medical, ArtFix, B-Balloon, Bio Protect, Bio Refine, Bluewhite, BrainQ, Cardio Gard, Cardiovalve, CartiHeal, ConAir Medical, Cordio, Curesign, DairyX, Digma, Eledon, Endomatic, Endostream, EviCure, Eximo, ExoProTher, Focal Medical Technology, Hairstetics, HeraCure, Insightec, Kahr, Kanso Diagnostics, Levation Pharma, Life Therapeutics, Magneto, Magnisity, Momentis Surgical, mPharma, NectinTx, Neovasc, NextVivo, NitiNotes, NLT, OncoRedox, Outsense, Raziel, Restore Medical, Ribon Therapeutics, SinuSafe, Snipe, SuperSpectra, Terrapeutics, Trojan Bio, Validify, Valtech, Variantyx, Visionsense, W Endoluminal Robotics, Wanda Fish, Xerient